Indaptus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 256,265 | $317,769 | 0.00% | 3.00% |
| INVESTMENT HOUSE LLC | 11/07/2024 | 99,976 | $123,970 | -2.40% | 1.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 73,129 | $90,691 | 23.30% | 0.86% |
| STRATEGY ASSET MANAGERS LLC | 11/08/2024 | 45,336 | $56,217 | 0.00% | 0.53% |
| PINE VALLEY INVESTMENTS LTD LIABILITY CO | 11/25/2024 | 43,983 | $54,539 | -0.23% | 0.51% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 27,100 | $33,604 | 1.88% | 0.32% |
| VIVALDI CAPITAL MANAGEMENT LP | 11/14/2024 | 24,000 | $29,760 | 0.00% | 0.28% |
| CITADEL ADVISORS LLC | 11/14/2024 | 15,390 | $19,084 | -30.71% | 0.18% |
| STATE STREET CORP | 11/14/2024 | 13,073 | $16,211 | 0.00% | 0.15% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 4,812 | $5,967 | 17.31% | 0.06% |
| MORGAN STANLEY | 11/14/2024 | 884 | $1,097 | 0.00% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 522 | $647 | -24.57% | 0.01% |
| BANGOR SAVINGS BANK | 10/07/2024 | 400 | $496 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 64 | $79 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 60 | $74 | 42.86% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 19 | $24 | 26.67% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 7 | $9 | 0.00% | 0.00% |
| FMR LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 10/02/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 12/02/2024 | 0 | $0 | -100.00% | 0.00% |
Indaptus Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Indaptus Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 256,265
INVESTMENT HOUSE LLC: 99,976
GEODE CAPITAL MANAGEMENT, LLC: 73,129
STRATEGY ASSET MANAGERS LLC: 45,336
Pine Valley Investments Ltd Liability Co: 43,983
RENAISSANCE TECHNOLOGIES LLC: 27,100
7.08% of Indaptus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 604,683 shares in the last 24 months. This purchase volume represents approximately $544,215 in transactions.